CPHI

3.80% -0.0098

Handel nachbörslich: .25 0.002 +0.81%

China Pharma Holdings Inc. (CPHI)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

China Pharma Holdings Inc. Stock (CPHI) Company Profile

China Pharma Holdings Inc.

Healthcare (1181)

86 898 6681 1730

No. 17, Jinpan Road, Second Floor, Haikou

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CPHI's Discussions on Twitter

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2010-01-08	Eingeleitet	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten

Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)

China Pharma Holdings Inc. (CPHI)

China Pharma Holdings Inc. Stock (CPHI) Company Profile

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

AstraZeneca says its China operations president under investigation - Reuters

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

RRJ Buys $150 Million Luye Bonds, First China Deal Since 2019 - BNN Bloomberg

Insiders of China Medical System Holdings Limited (HKG:867) must be disappointed as stock fell 4.7% after recent purchases - Simply Wall St

AI Redefines the Pharmaceuticals Wholesale and Distribution Market, Projected to Grow by USD 896.5 Billion from 2024-2028, Boosting Global Sales - The Malaysian Reserve

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com - Defense World

China Constipation Treatment Drug Industry Growth Factors, Applications, and Forecast by (2024-2034) - IndiaPolitics.com

China Pharma Holdings Inc. (CPHI) is a good investment, but the stock may be undervalued - US Post News

The Psychology of China Pharma Holdings Inc. Inc. (CPHI) Price Performance: Understanding Market Sentiment - The InvestChronicle

CPHI’s 52-Week Rollercoaster: From $0.17 to $1.21 – What’s Next for Investors? - The InvestChronicle

Analytical Overview: China Pharma Holdings Inc. (CPHI)’s Ratios Tell a Financial Story - The Dwinnex

China's WuXi explores sale of pharma operations as US restrictions loom, FT reports - Yahoo Finance

Check out these key findings about China Pharma Holdings Inc. (CPHI) - SETE News

PDD Holdings: China Stimulus Adds Rocket Fuel, Reiterate Buy - Seeking Alpha

LEO Pharma announces Enstilar NDA submission for plaque psoriasis in China - Yahoo Finance

Here's Why Yum China Holdings (YUMC) is a Strong Growth Stock - Yahoo Finance

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World

CPHI’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China - Yahoo Finance

Haleon Increases Stake in China JV to 88% for GBP500 Million - Marketscreener.com

China's Bold Stimulus Measures: What It Means for Markets - Saxo Bank

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) - Yahoo Finance

CSPC Pharma taps R&D superstar in quest for new breakout drugs - Bamboo Works

StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World

Yum China Holdings, Inc. (YUMC): Analysts Are Bullish On This Undervalued Cyclical Stock Now - Yahoo Finance

Investing in China Pharma Holdings Inc. (CPHI) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News

China Pharma Holdings Inc.: Weathering Stock Market Storms with 4.04M Market Cap - The InvestChronicle

China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com - Defense World

Big pharma eyes China ‘at forefront of GLP-1 revolution’ - BioWorld Online

US House Passes Bill to Blacklist Some China Biotech Firms - Yahoo Finance

Summit’s checkpoint inhibitor trumps Keytruda in lung cancer trial - Clinical Trials Arena

Plasma Fractionation Market Size to Expand Lucratively by 2031 - WhaTech

Stocks to Watch, Sep 6: Glenmark Pharma, Godfrey, Max Fin Svcs, Pidilite - Business Standard

AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities - Yahoo Finance

China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World

China Medical System Holdings First Half 2024 Earnings: EPS: CN¥0.37 (vs CN¥0.78 in 1H 2023) - Simply Wall St

Jacobio Pharma grants Allist rights to two assets in China - Yahoo Finance

Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer's Top Stock Picks For the Next 12 Months - MSN

HSI Down 182 pts; HSTI Down 55 pts; MEITUAN Down over 3%; HANSOH PHARMA, CKI HOLDINGS, CLP HOLDINGS, CHINA TAIPING, ASCENTAGE Hit New Highs - AASTOCKS.com

HSI Closes Midday at 17,700, Down 173 pts; HSTI Closes Midday at 3,437, Down 63 pts; NONGFU SPRING Down over 11%; HANSOH PHARMA, CKI HOLDINGS, CLP HOLDINGS, CKH HOLDINGS, CHINA TAIPING Hit New Highs - AASTOCKS.com

Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer’s Top Stock Picks For the Next 12 Months - Insider Monkey

China Nt Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2020 - Marketscreener.com

Belgium's UCB to sell China neurology, allergy business for $680 mln - Reuters

Mayne Pharma Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network

Vanguard Group Inc. Increases Stake in iShares MSCI China ETF (NASDAQ:MCHI) - Defense World

TopBrand 2024 Top 500 Global Brands List released, with Apple as defending champion - The Manila Times

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 - The Manila Times

Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CPHI